Interestingly, increased production of LOXL1 from CAFs regulated by tumor cell-derived TGF-β and SMAD signaling pathway activation could enhance tumor metastasis via ECM remodeling (Zeltz, et al. 2019). This evidence concerns the gene LOXL1 and neoplasm.